Phibro Animal Health (PAHC) Competitors $19.44 -0.78 (-3.83%) As of 01:25 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock PAHC vs. ALVO, RYTM, MRUS, CRNX, IMVT, VKTX, PTGX, SRRK, BHVN, and CPRXShould you be buying Phibro Animal Health stock or one of its competitors? The main competitors of Phibro Animal Health include Alvotech (ALVO), Rhythm Pharmaceuticals (RYTM), Merus (MRUS), Crinetics Pharmaceuticals (CRNX), Immunovant (IMVT), Viking Therapeutics (VKTX), Protagonist Therapeutics (PTGX), Scholar Rock (SRRK), Biohaven (BHVN), and Catalyst Pharmaceuticals (CPRX). These companies are all part of the "pharmaceutical products" industry. Phibro Animal Health vs. Alvotech Rhythm Pharmaceuticals Merus Crinetics Pharmaceuticals Immunovant Viking Therapeutics Protagonist Therapeutics Scholar Rock Biohaven Catalyst Pharmaceuticals Phibro Animal Health (NASDAQ:PAHC) and Alvotech (NASDAQ:ALVO) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, risk, profitability, institutional ownership, media sentiment, valuation, community ranking, earnings and analyst recommendations. Which has more volatility and risk, PAHC or ALVO? Phibro Animal Health has a beta of 0.58, meaning that its share price is 42% less volatile than the S&P 500. Comparatively, Alvotech has a beta of -0.16, meaning that its share price is 116% less volatile than the S&P 500. Which has stronger valuation and earnings, PAHC or ALVO? Phibro Animal Health has higher revenue and earnings than Alvotech. Alvotech is trading at a lower price-to-earnings ratio than Phibro Animal Health, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPhibro Animal Health$1.11B0.74$2.42M$0.4842.13Alvotech$391.87M7.13-$551.73M-$0.87-10.66 Is PAHC or ALVO more profitable? Phibro Animal Health has a net margin of 1.75% compared to Alvotech's net margin of -123.47%. Phibro Animal Health's return on equity of 25.35% beat Alvotech's return on equity.Company Net Margins Return on Equity Return on Assets Phibro Animal Health1.75% 25.35% 6.21% Alvotech -123.47%N/A -35.87% Do analysts prefer PAHC or ALVO? Phibro Animal Health currently has a consensus price target of $21.00, indicating a potential upside of 3.86%. Alvotech has a consensus price target of $18.00, indicating a potential upside of 94.17%. Given Alvotech's stronger consensus rating and higher probable upside, analysts plainly believe Alvotech is more favorable than Phibro Animal Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Phibro Animal Health 2 Sell rating(s) 2 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.50Alvotech 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the MarketBeat Community believe in PAHC or ALVO? Phibro Animal Health received 309 more outperform votes than Alvotech when rated by MarketBeat users. Likewise, 59.96% of users gave Phibro Animal Health an outperform vote while only 50.00% of users gave Alvotech an outperform vote. CompanyUnderperformOutperformPhibro Animal HealthOutperform Votes31659.96% Underperform Votes21140.04% AlvotechOutperform Votes750.00% Underperform Votes750.00% Does the media prefer PAHC or ALVO? In the previous week, Alvotech had 4 more articles in the media than Phibro Animal Health. MarketBeat recorded 7 mentions for Alvotech and 3 mentions for Phibro Animal Health. Phibro Animal Health's average media sentiment score of 1.20 beat Alvotech's score of 0.35 indicating that Phibro Animal Health is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Phibro Animal Health 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Alvotech 2 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do insiders & institutionals believe in PAHC or ALVO? 99.3% of Phibro Animal Health shares are held by institutional investors. 50.1% of Phibro Animal Health shares are held by insiders. Comparatively, 0.5% of Alvotech shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. SummaryPhibro Animal Health beats Alvotech on 13 of the 18 factors compared between the two stocks. Remove Ads Get Phibro Animal Health News Delivered to You Automatically Sign up to receive the latest news and ratings for PAHC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PAHC vs. The Competition Export to ExcelMetricPhibro Animal HealthPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$818.97M$6.73B$5.54B$7.49BDividend Yield2.24%2.79%4.86%4.04%P/E Ratio42.136.9923.2518.07Price / Sales0.74198.60361.2586.83Price / Cash10.8765.6738.1634.64Price / Book3.325.926.493.99Net Income$2.42M$142.37M$3.21B$247.18M7 Day Performance-5.78%-7.24%-4.89%-4.25%1 Month Performance-16.00%-10.45%-0.07%-6.87%1 Year Performance56.74%-14.58%6.41%-3.73% Phibro Animal Health Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PAHCPhibro Animal Health3.5651 of 5 stars$19.41-4.0%$21.00+8.2%+56.4%$786.12M$1.11B40.441,860News CoveragePositive NewsGap DownALVOAlvotech1.8202 of 5 stars$11.56-0.1%$18.00+55.7%-20.7%$3.49B$391.87M-6.251,026Gap DownRYTMRhythm Pharmaceuticals4.3773 of 5 stars$53.72+3.2%$69.46+29.3%+21.8%$3.40B$130.13M-12.41140Gap DownMRUSMerus1.847 of 5 stars$48.77+3.2%$85.31+74.9%-6.4%$3.37B$36.13M-12.3537News CoverageGap DownCRNXCrinetics Pharmaceuticals4.3137 of 5 stars$35.94+4.4%$74.30+106.7%-39.4%$3.34B$1.04M-9.64210News CoveragePositive NewsGap DownIMVTImmunovant2.1848 of 5 stars$19.44-1.0%$41.70+114.5%-49.4%$3.30BN/A-7.42120Gap DownVKTXViking Therapeutics4.3255 of 5 stars$29.28+1.1%$97.67+233.6%-69.1%$3.29BN/A-29.2820Gap DownPTGXProtagonist Therapeutics3.3101 of 5 stars$52.53-0.2%$62.56+19.1%+65.7%$3.22B$434.43M19.75120Gap DownHigh Trading VolumeSRRKScholar Rock4.0367 of 5 stars$33.81+2.3%$40.86+20.8%+101.6%$3.20B$33.19M-14.39140News CoveragePositive NewsGap DownBHVNBiohaven4.0788 of 5 stars$30.97+8.5%$63.15+103.9%-60.8%$3.16BN/A-3.31239News CoverageGap DownCPRXCatalyst Pharmaceuticals4.8262 of 5 stars$25.74+6.2%$32.29+25.4%+55.6%$3.13B$491.73M21.8180Positive NewsGap DownHigh Trading Volume Remove Ads Related Companies and Tools Related Companies ALVO Competitors RYTM Competitors MRUS Competitors CRNX Competitors IMVT Competitors VKTX Competitors PTGX Competitors SRRK Competitors BHVN Competitors CPRX Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PAHC) was last updated on 4/4/2025 by MarketBeat.com Staff From Our PartnersTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | SponsoredYour Retirement Is Caught in the CrossfireWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredRUTHLESS Musk Move >> coming June 1?Elon Musk has made headlines with everything from mass layoffs to political drama — but his next move could sh...Paradigm Press | SponsoredNearly $3 Trillion Gone…Nearly $3 trillion disappeared from the stock market on Thursday morning. According to Whitney Tilson - a f...Stansberry Research | SponsoredHow you could profit from Elon’s latest AI breakthroughEvery single one of Elon's projects minted an entire new class of millionaires. And xAI could be next in li...Behind the Markets | Sponsored🥾⛏️👷♂️ What I Learned From Numerous Mine Visits...Twenty years ago, I made a decision that changed my life. Instead of sitting behind a desk analyzing mining...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Phibro Animal Health Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Phibro Animal Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy PAHC Stock Free PAHC Stock Alerts